Ceremorphic Life Sciences Demonstrates New BioSupercomputing Platform That Can Speed Every Phase of Drug Discovery and Development
Ceremorphic Life Sciences CEO Venkat Mattela delivered the keynote at AI Driven Drug Discovery Summit in Boston MA recently where he demonstrated the companys new BioCompDiscoverX supercomputing platform.
United States Venkat Mattela Ceremorphic Life Sciences Ceremorphic Inc Drug Discovery Summit Ceremorphic Life Sciences Ai Drug Discovery Summit Biocompdiscoverx Technology Development Pharmaceutical Industry Venkat Mattela Supercomputing Quantum Circuits Silico Models Silicon Technologies Simulation Vaccine Generation Dr William Haseltine Human Genome Generative
Source: businesswireindia.com